183 related articles for article (PubMed ID: 30175217)
1. Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.
Ogunsanya ME; Brown CM; Lin D; Imarhia F; Maxey C; Chong BF
Int J Womens Dermatol; 2018 Sep; 4(3):152-158. PubMed ID: 30175217
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Perspectives of Patients Living With Lupus: Retrospective Social Listening Study.
Spies E; Andreu T; Hartung M; Park J; Kamudoni P
JMIR Form Res; 2024 Feb; 8():e52768. PubMed ID: 38306157
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lupus concerns from the patient perspective: a qualitative study.
Yan D; Zamalin D; Chakka S; Krain R; Concha J; Feng R; Ahmed S; Okawa J; Werth VP
Lupus Sci Med; 2021 Aug; 8(1):. PubMed ID: 34452954
[TBL] [Abstract][Full Text] [Related]
4. Treatments for disease damage in cutaneous lupus erythematosus: A narrative review.
Joseph AK; Abbas LF; Chong BF
Dermatol Ther; 2021 Sep; 34(5):e15034. PubMed ID: 34151487
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus.
Ogunsanya ME; Kalb SJ; Kabaria A; Chen S
Br J Dermatol; 2017 Jan; 176(1):52-61. PubMed ID: 27416958
[TBL] [Abstract][Full Text] [Related]
6. The Burden of Living With Cutaneous Lupus Erythematosus.
Drenkard C; Barbour KE; Greenlund KJ; Lim SS
Front Med (Lausanne); 2022; 9():897987. PubMed ID: 36017007
[TBL] [Abstract][Full Text] [Related]
7. Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.
Ogunsanya ME; Cho SK; Hudson A; Chong BF
Br J Dermatol; 2019 Jun; 180(6):1430-1437. PubMed ID: 30637718
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.
Ogunsanya ME; Cho SK; Hudson A; Chong BF
Lupus; 2020 Nov; 29(13):1691-1703. PubMed ID: 32883161
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lupus erythematosus: An update.
Grönhagen CM; Nyberg F
Indian Dermatol Online J; 2014 Jan; 5(1):7-13. PubMed ID: 24616847
[TBL] [Abstract][Full Text] [Related]
10. The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.
Chakka S; Krain RL; Concha JSS; Chong BF; Merola JF; Werth VP
Ann Transl Med; 2021 Mar; 9(5):431. PubMed ID: 33842652
[TBL] [Abstract][Full Text] [Related]
11. The classification and diagnosis of cutaneous lupus erythematosus.
Kuhn A; Landmann A
J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.
Vasquez R; Wang D; Tran QP; Adams-Huet B; Chren MM; Costner MI; Cohen JB; Werth VP; Chong BF
Br J Dermatol; 2013 Jan; 168(1):145-53. PubMed ID: 22708924
[TBL] [Abstract][Full Text] [Related]
13. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians.
Chanprapaph K; Tankunakorn J; Suchonwanit P; Rutnin S
Dermatol Ther (Heidelb); 2021 Feb; 11(1):131-147. PubMed ID: 33280074
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
15. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
16. Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels.
Joseph A; Prasad S; Hynan LS; Chren MM; Chong B
Lupus; 2021 May; 30(6):972-980. PubMed ID: 33663251
[TBL] [Abstract][Full Text] [Related]
17. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
[TBL] [Abstract][Full Text] [Related]
18. Willingness-to-pay stated preferences in cutaneous lupus erythematosus: a pilot study.
Liu SW; Tkachenko E; Lam C; Alsarheed A; Cobos G; Lo K; Femia A; Qureshi AA; Vleugels RA
Arch Dermatol Res; 2020 Sep; 312(7):527-531. PubMed ID: 31773259
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
[TBL] [Abstract][Full Text] [Related]
20. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
